Publications

Want to be in the know about the latest advances in diabetes research? Need more information on how to live well with T1D? Connect with us on social networking sites, subscribe to our emails, and check out our print and online materials.



Countdown

  • Making the T1D Vaccine a Reality

    Nanoparticle-based vaccine is designed to re-educate the immune system and halt the attack on the pancreas Over the last three years, Selecta Bioscience, a clinical stage biotechnology company, has been developing nanoparticles called Synthetic Vaccine Particle (SVP) as an immunotherapy for Type 1 diabetes (T1D) with support from JDRF and it was announced this week […]

    Read More

  • JDRF-Funded Research Leads to Beta Cell Replacement Breakthrough

    A new method for converting stem cells to beta cells could speed encapsulated cell replacement product development and research to cure type 1 diabetes Insulin therapy has long been the only method of treating type 1 diabetes (T1D), but a major breakthrough in producing replacement beta cells is bringing new hope that more effective, alternative […]

    Read More

  • JDRF 2015 Children’s Congress application site remains open

    JDRF is pleased to announce that applications for JDRF 2015 Children’s Congress are currently being accepted. JDRF Children’s Congress, our highest profile advocacy event, is held every two years in the nation’s capital. Next year’s event will take place from July 13 to 15, 2015. It will include more than 150 children, ages 4 to […]

    Read More

  • A New Pathway to Beta Cells

    Innovative process could increase beta cell supply for type 1 diabetes research and encapsulated cell replacement products An important new technique to more rapidly convert human embryonic stem cells (hESCs) into cells similar to pancreatic beta cells was reported recently in Nature Biotechnology. In a study partially funded by JDRF, Dr. Timothy Kieffer of the […]

    Read More

  • CGM-Medicare Bill Introduced in House

    JDRF Commends U.S. Representatives Reed, DeGette and Whitfield for Introducing Continuous Glucose Monitor (CGM) Coverage Legislation JDRF commends U.S. Representatives Tom Reed (R-NY), Diana DeGette (D-CO) and Ed Whitfield (R-KY) for introducing legislation, H.R. 5644, the ‘Medicare CGM Access Act of 2014,’ calling for continuous glucose monitor (CGM) coverage by Medicare. This legislation (which now […]

    Read More